3 results
The current study will investigate whether the FSL can be used to establish the diagnosis GDM in women who became pregnant after bariatric surgery. To accomplish this, first it will be necessary to gain insight into the continuous glucose pattern of…
* To assess the safety and tolerability of Ampligen administered intranasally in a dosing schedule for 13 days (7 doses) in healthy subjects.* To characterize the mucosal immune response following Ampligen administration over time.
The primary objective of the safety run-in (phase Ib) is to determine the safety of combination therapy with durvalumab and rintatolimod. The primary objective of the phase II trial is to determine the clinical benefit rate of combination therapy…